UCSF Psychiatry News

The 2018 UCSF Weill Institute for Neurosciences Symposium, hosted by Weill Cornell Medicine, will be held on Friday, November 9, in New York City.

The UCSF Department of Psychiatry, along with the San Francisco chapter of the American Foundation for Suicide Prevention (AFSP), will host a morning of reflection, discussion, and support on Saturday, November 17, 2018, for International Survivors of Suicide Loss Day.

National Institute on Minority Health and Health Disparities (NIMHD) Director Eliseo J. Pérez-Stable, MD, will deliver the 14th annual Dr. Evelyn Lee Visiting Scholar Lecture in Cultural Competency and Diversity on Tuesday, October 30, as part of the Department of Psychiatry’s Grand Rounds series.

In the largest DNA sequencing study of Tourette disorder (TD) to date, UC San Francisco researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development of this condition.

The UCSF Department of Psychiatry and San Francisco Marin Medical Society invite all medical professionals and trainees to a reception for American Medical Association (AMA) President-Elect Patrice A. Harris, MD, MA.

Seven members of the University of California, San Francisco Department of Psychiatry faculty have been selected for recognition by the Haile T. Debas Academy of Medical Educators

A $20 million gift from longtime UC San Francisco donors Dagmar Dolby and her son, David, will establish the UCSF Dolby Family Center for Mood Disorders within the Department of Psychiatry.

The University of California, San Francisco has named longtime UCSF Psychiatry faculty member Kim P. Norman, MD, as the inaugural UCSF Distinguished Professor for Adolescent and Young Adult Health

A new study has identified at-risk populations for whom depression screening combined with hazardous alcohol use screening could detect depressive symptoms that might otherwise go untreated. These populations include non-white and more medically ill patients, and men in general, for whom screening rates are particularly low.

Scientists have struggled for decades to crack the code of psychiatric disorders, but advances in understanding the biology of these conditions have not led to a successful new therapy in 70 years. Now a group of biologists, psychiatrists, and geneticists led by researchers at UC San Francisco and the Gladstone Institutes is leveraging that progress to forge a new path toward novel treatments for these conditions.